Correlation Between Vivos Therapeutics and Neuronetics

Can any of the company-specific risk be diversified away by investing in both Vivos Therapeutics and Neuronetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vivos Therapeutics and Neuronetics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vivos Therapeutics and Neuronetics, you can compare the effects of market volatilities on Vivos Therapeutics and Neuronetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vivos Therapeutics with a short position of Neuronetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vivos Therapeutics and Neuronetics.

Diversification Opportunities for Vivos Therapeutics and Neuronetics

0.02

Correlation Coefficient

Vivos Therapeutics  Neuronetics

Significant diversification

The 3 months correlation between Vivos and Neuronetics is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Vivos Therapeutics and Neuronetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuronetics and Vivos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vivos Therapeutics are associated (or correlated) with Neuronetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuronetics has no effect on the direction of Vivos Therapeutics i.e., Vivos Therapeutics and Neuronetics go up and down completely randomly.

Pair Corralation between Vivos Therapeutics and Neuronetics

Given the investment horizon of 90 days Vivos Therapeutics is expected to generate 2.31 times more return on investment than Neuronetics. However, Vivos Therapeutics is 2.31 times more volatile than Neuronetics. It trades about 0.11 of its potential returns per unit of risk. Neuronetics is currently generating about 0.01 per unit of risk. If you would invest  314.00  in Vivos Therapeutics on May 11, 2025 and sell it today you would earn a total of  126.00  from holding Vivos Therapeutics or generate 40.13% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Vivos Therapeutics  vs.  Neuronetics

Vivos Therapeutics

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Vivos Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively abnormal basic indicators, Vivos Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Neuronetics

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Neuronetics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy forward indicators, Neuronetics is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Vivos Therapeutics and Neuronetics

The main advantage of trading using opposite Vivos Therapeutics and Neuronetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vivos Therapeutics position performs unexpectedly, Neuronetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuronetics will offset losses from the drop in Neuronetics' long position.

The idea behind Vivos Therapeutics and Neuronetics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.